Mostrando 5 resultados de: 5
Filtros aplicados
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(3)
Salud y seguridad personal(2)
Alimentación y bebidas(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
google(2)
Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al.
OtherAbstract:Palabras claves:Autores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusDrug holidays from bisphosphonates and denosumab in postmenopausal osteoporosis: EMAS position statement
ReviewAbstract: Background Bisphosphonates and denosumab are used extensively in the treatment of postmenopausal ostPalabras claves:Alendronate, Bisphosphonates, Denosumab, Drug holiday, Risedronate, Zoledronic acidAutores:Anagnostis P., Ceausu I., Depypere H., Faustino R. Pérez-López, Goulis D.G., Lambrinoudaki I., Mintziori G., Mueck A., Paschou S.A., Rees M., Senturk L.M., Simoncini T., Stevenson J.C., Stute P., Trémollieres F.A.Fuentes:scopusNutritional guidelines for the management of insulin resistance
ReviewAbstract: Obesity and its related co-morbidities, namely type 2 diabetes (T2D), pose a significant global publPalabras claves:Guidelines, Insulin Resistance, nutrition management, obesity, Polycystic ovary syndrome, Type 2 DiabetesAutores:Barrea L., Caprio M., Ceriani F., Chavez A.O., Colao A., El Ghoch M., Frias Toral Evelyn, Mehta R.J., Mendez V., MUScogiUri G., Paschou S.A., Pazderska A., SaVaSTaNo S.Fuentes:googlescopusNutritional management of type 2 diabetes in subjects with obesity: an international guideline for clinical practice
ReviewAbstract: Type 2 diabetes mellitus (T2DM) and obesity represent a global public health problem. Current nutritPalabras claves:diet, nutritionist, obesity, personalized nutrition, Type 2 Diabetes mellitusAutores:Barrea L., Caprio M., Colao A., El Ghoch M., Frias Toral Evelyn, Mehta R.J., Mendez V., Moriconi E., MUScogiUri G., Paschou S.A., Pazderska A., SaVaSTaNo S., Vetrani C.Fuentes:googlescopusMenopause and diabetes: EMAS clinical guide
ArticleAbstract: Introduction: Whether menopause increases the risk of type 2 diabetes mellitus (T2DM) independentlyPalabras claves:menopausal hormone therapy, MENOPAUSE, Type 2 Diabetes mellitusAutores:Anagnostis P., Cano A., Goulis D.G., Jaremek J.D., Lambrinoudaki I., Lopes P., Meczekalski B., Mishra G.D., Mueck A., Paschou S.A., Peter A. Chedraui, Rees M., Rogowicz-Frontczak A., Senturk L.M., Simoncini T., Slopien R., Stevenson J.C., Stute P., Tuomikoski P., Wender-Ozegowska E., Zozulinska-Ziolkiewicz D.Fuentes:scopus